PolyMedix is a clinical stage biotechnology company devoted to transforming the treatment of infectious diseases. The company is engaged in developing defensin-mimetics, a new class of antibiotics for treating serious, life-threatening infections that often develop resistance to antibiotics that are currently available. PolyMedix’s compounds are created to mimic the mechanism of action of host defense proteins, which contribute to natural human immunity. For more information, visit the company’s Web site at www.polymedix.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: